{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:57:26Z","timestamp":1721649446644},"reference-count":38,"publisher":"Japanese Society of Toxicologic Pathology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1293\/tox.2018-0045","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T22:03:23Z","timestamp":1562277803000},"page":"223-232","source":"Crossref","is-referenced-by-count":2,"title":["Proteomics approach to investigate dynamic protein profile involved in high          fat diet-induced fatty liver disease in rats"],"prefix":"10.1293","volume":"32","author":[{"given":"Baohua","family":"Huang","sequence":"first","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Yao","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huchen","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Genetics, Guangxi              Medical University, 22 Shuangyong Road, Nanning city, Guangxi Province, 530021,              China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Genetics, Guangxi              Medical University, 22 Shuangyong Road, Nanning city, Guangxi Province, 530021,              China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Genetics, Guangxi              Medical University, 22 Shuangyong Road, Nanning city, Guangxi Province, 530021,              China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Chemistry and Molecular              Engineering of Medical Resources, Guangxi Normal University, 15 Yucai Road, Guilin              city, Guangxi Province, 541004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Chen              M,                Ying              W,                Song              Y,                Liu              X,                Yang              B,                Wu              S,                Jiang              Y,                Cai              Y,                He              F, and                Qian              X. Analysis of            human liver proteome using replicate shotgun strategy.            Proteomics. 7:          2479\u20132488. 2007.","DOI":"10.1002\/pmic.200600338"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Beretta              L. HUPO\u2019s            effort to define the liver proteome. J Proteome Res.            9: 637\u2013638. 2010.","DOI":"10.1021\/pr100011s"},{"key":"3","unstructured":"3.  Davis              GL, and                Keeffe              EB. Advances in            liver disease. Highlights from the 51st Annual Meeting of the American Association for            the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.            Rev Gastroenterol Disord. 1:            42\u201347. 2001."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Jacobson              IM,                Davis              GL,                El-Serag              H,                Negro              F, and                Tr\u00e9po              C. Prevalence            and challenges of liver diseases in patients with chronic hepatitis C virus            infection. Clin Gastroenterol Hepatol.            8: 924\u2013933, quiz e117. 2010.","DOI":"10.1016\/j.cgh.2010.06.032"},{"key":"5","unstructured":"5.  Bernal                Reyes              R. [Liver            diseases. Non-alcoholic fatty liver disease]. Rev Gastroenterol            Mex. 75(Suppl 1):            181\u2013183. 2010."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Mikolasevic              I,                Milic              S,                Racki              S,                Zaputovic              L,                Stimac              D,                Radic              M,                Markic              D, and                Orlic              L. Nonalcoholic            fatty liver disease (NAFLD)-a new cardiovascular risk factor in peritoneal dialysis            patients. Perit Dial Int:            427\u2013432. 2016.","DOI":"10.3747\/pdi.2014.00223"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7.  Marrero              JA,                Fontana              RJ,                Su              GL,                Conjeevaram              HS,                Emick              DM, and                Lok              AS. NAFLD may            be a common underlying liver disease in patients with hepatocellular carcinoma in the            United States. Hepatology. 36:            1349\u20131354. 2002.","DOI":"10.1053\/jhep.2002.36939"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Younossi              ZM,                Otgonsuren              M,                Henry              L,                Venkatesan              C,                Mishra              A,                Erario              M, and                Hunt              S. Association            of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the            United States from 2004 to 2009. Hepatology.            62: 1723\u20131730. 2015.","DOI":"10.1002\/hep.28123"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Allard              JP. Other            disease associations with non-alcoholic fatty liver disease (NAFLD).            Best Pract Res Clin Gastroenterol. 16:            783\u2013795. 2002.","DOI":"10.1053\/bega.2002.0330"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Almobarak              AO,                Barakat              S,                Khalifa              MH,                Elhoweris              MH,                Elhassan              TM, and                Ahmed              MH. Non            alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence            and risk factors?          Arab J Gastroenterol. 15:            12\u201315. 2014.","DOI":"10.1016\/j.ajg.2014.01.008"},{"key":"11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","year":"2005","unstructured":"11.  Adams              LA,                Lymp              JF,                St Sauver              J,                Sanderson              SO,                Lindor              KD,                Feldstein              A, and                Angulo              P. The natural            history of nonalcoholic fatty liver disease: a population-based cohort            study. Gastroenterology. 129:            113\u2013121. 2005.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","year":"1999","unstructured":"12.  Matteoni              CA,                Younossi              ZM,                Gramlich              T,                Boparai              N,                Liu              YC, and                McCullough              AJ.            Nonalcoholic fatty liver disease: a spectrum of clinical and pathological            severity. Gastroenterology. 116:            1413\u20131419. 1999.","journal-title":"Gastroenterology","ISSN":"http:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Tannu              NS, and                Hemby              SE.            Two-dimensional fluorescence difference gel electrophoresis for            comparative proteomics profiling. Nat Protoc.            1: 1732\u20131742. 2006.","DOI":"10.1038\/nprot.2006.256"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.  Qian              WJ,                Jacobs              JM,                Liu              T,                Camp                  DG 2nd,          and Smith              RD. Advances            and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for            clinical applications. Mol Cell Proteomics.            5: 1727\u20131744. 2006.","DOI":"10.1074\/mcp.M600162-MCP200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15.  Gharbi              S,                Gaffney              P,                Yang              A,                Zvelebil              MJ,                Cramer              R,                Waterfield              MD, and                Timms              JF. Evaluation            of two-dimensional differential gel electrophoresis for proteomic expression analysis of            a model breast cancer cell system. Mol Cell Proteomics.            1: 91\u201398. 2002.","DOI":"10.1074\/mcp.T100007-MCP200"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16.  Zhang              X,                Yang              J,                Guo              Y,                Ye              H,                Yu              C,                Xu              C,                Xu              L,                Wu              S,                Sun              W,                Wei              H,                Gao              X,                Zhu              Y,                Qian              X,                Jiang              Y,                Li              Y, and                He              F. Functional            proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a            hydratase down-regulation exacerbates hepatic steatosis.            Hepatology. 51:            1190\u20131199. 2010.","DOI":"10.1002\/hep.23486"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Chen              M,                Wang              Y,                Zhao              Y,                Wang              L,                Gong              J,                Wu              L,                Gao              X,                Yang              Z, and                Qian              L. Dynamic            proteomic and metabonomic analysis reveal dysfunction and subclinical injury in rat            liver during restraint stress. Biochim Biophys Acta.            1794: 1751\u20131765. 2009.","DOI":"10.1016\/j.bbapap.2009.08.012"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18.  Feldstein              AE,                Werneburg              NW,                Canbay              A,                Guicciardi              ME,                Bronk              SF,                Rydzewski              R,                Burgart              LJ, and                Gores              GJ. Free fatty            acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal            pathway. Hepatology. 40:            185\u2013194. 2004.","DOI":"10.1002\/hep.20283"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19.  Schm\u00f6cker              C,                Weylandt              KH,                Kahlke              L,                Wang              J,                Lobeck              H,                Tiegs              G,                Berg              T, and                Kang              JX. Omega-3            fatty acids alleviate chemically induced acute hepatitis by suppression of            cytokines. Hepatology. 45:            864\u2013869. 2007.","DOI":"10.1002\/hep.21626"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Bell              LN,                Theodorakis              JL,                Vuppalanchi              R,                Saxena              R,                Bemis              KG,                Wang              M, and                Chalasani              N. Serum            proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver            disease. Hepatology. 51:            111\u2013120. 2010.","DOI":"10.1002\/hep.23271"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Yilmaz              Y. Serum            proteomics for biomarker discovery in nonalcoholic fatty liver disease.            Clin Chim Acta. 413:            1190\u20131193. 2012.","DOI":"10.1016\/j.cca.2012.04.019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22.  Nu\u00f1o-L\u00e1mbarri              N,                Barbero-Becerra              VJ,                Uribe              M, and                Ch\u00e1vez-Tapia              NC.            Mitochondrial molecular pathophysiology of nonalcoholic fatty liver            disease: a proteomics approach. Int J Mol Sci.            17: 281. 2016.","DOI":"10.3390\/ijms17030281"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.  Tsai              MT,                Chen              YJ,                Chen              CY,                Tsai              MH,                Han              CL,                Chen              YJ,                Mersmann              HJ, and                Ding              ST.            Identification of potential plasma biomarkers for nonalcoholic fatty            liver disease by integrating transcriptomics and proteomics in laying            hens. J Nutr. 147:            293\u2013303. 2017.","DOI":"10.3945\/jn.116.240358"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  You              Y,                Zhang              Y,                Lu              Y,                Hu              K,                Qu              X,                Liu              Y,                Lu              B, and                Jin              L. Protein            profiling and functional analysis of liver mitochondria from rats with nonalcoholic            steatohepatitis. Mol Med Rep. 16:            2379\u20132388. 2017.","DOI":"10.3892\/mmr.2017.6893"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.  Rao              PK,                Merath              K,                Drigalenko              E,                Jadhav              AYL,                Komorowski              RA,                Goldblatt              MI,                Rohatgi              A,                Sarzynski              MA,                Gawrieh              S, and                Olivier              M. Proteomic            characterization of high-density lipoprotein particles in patients with non-alcoholic            fatty liver disease. Clin Proteomics.            15: 10. 2018.","DOI":"10.1186\/s12014-018-9186-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26.  Spanos              C,                Maldonado              EM,                Fisher              CP,                Leenutaphong              P,                Oviedo-Orta              E,                Windridge              D,                Salguero              FJ,                Berm\u00fadez-Fajardo              A,                Weeks              ME,                Evans              C,                Corfe              BM,                Rabbani              N,                Thornalley              PJ,                Miller              MH,                Wang              H,                Dillon              JF,                Quaglia              A,                Dhawan              A,                Fitzpatrick              E, and                Bernadette Moore              J. Proteomic            identification and characterization of hepatic glyoxalase 1 dysregulation in            non-alcoholic fatty liver disease. Proteome Sci.            16: 4. 2018.","DOI":"10.1186\/s12953-018-0131-y"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.  Patel              MS,                Korotchkina              LG, and                Sidhu              S. Interaction            of E1 and E3 components with the core proteins of the human pyruvate dehydrogenase            complex. J Mol Catal, B Enzym. 61:            2\u20136. 2009.","DOI":"10.1016\/j.molcatb.2009.05.001"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28.  Kim              SY,                Lee              PY,                Shin              HJ,                Kim              DH,                Kang              S,                Moon              HB,                Kang              SW,                Kim              JM,                Park              SG,                Park              BC,                Yu              DY,                Bae              KH, and                Lee              SC. Proteomic            analysis of liver tissue from HBx-transgenic mice at early stages of            hepatocarcinogenesis. Proteomics. 9:            5056\u20135066. 2009.","DOI":"10.1002\/pmic.200800779"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.  Aldred              S,                Sozzi              T,                Mudway              I,                Grant              MM,                Neubert              H,                Kelly              FJ, and                Griffiths              HR. Alpha            tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy            subjects. Proteomics. 6:            1695\u20131703. 2006.","DOI":"10.1002\/pmic.200500217"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30.  Ogasawara              K,                Mashiba              S,                Hashimoto              H,                Kojima              S,                Matsuno              S,                Takeya              M,                Uchida              K, and                Yajima              J. Low-density            lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of            coronary artery disease. Clin Chim Acta.            397: 42\u201347. 2008.","DOI":"10.1016\/j.cca.2008.07.014"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31.  Jiang              J,                Nilsson-Ehle              P, and                Xu              N. Influence of            liver cancer on lipid and lipoprotein metabolism. Lipids Health            Dis. 5: 4. 2006.","DOI":"10.1186\/1476-511X-5-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32.  Di                Costanzo              L,                Drury              JE,                Christianson              DW, and                Penning              TM. Structure            and catalytic mechanism of human steroid 5beta-reductase (AKR1D1).            Mol Cell Endocrinol. 301:            191\u2013198. 2009.","DOI":"10.1016\/j.mce.2008.09.013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33.  Lee              WH,                Lukacik              P,                Guo              K,                Ugochukwu              E,                Kavanagh              KL,                Marsden              B, and                Oppermann              U.            Structure-activity relationships of human AKR-type oxidoreductases            involved in bile acid synthesis: AKR1D1 and AKR1C4. Mol Cell            Endocrinol. 301: 199\u2013204.            2009.","DOI":"10.1016\/j.mce.2008.09.042"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34.  Kumar              A,                Sharma              A,                Duseja              A,                Das              A,                Dhiman              RK,                Chawla              YK,                Kohli              KK, and                Bhansali              A. Patients            with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison            to chronic viral hepatitis. J Clin Exp Hepatol.            3: 12\u201318. 2013.","DOI":"10.1016\/j.jceh.2012.10.009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35.  Madan              K,                Bhardwaj              P,                Thareja              S,                Gupta              SD, and                Saraya              A. Oxidant            stress and antioxidant status among patients with nonalcoholic fatty liver disease            (NAFLD). J Clin Gastroenterol. 40:            930\u2013935. 2006.","DOI":"10.1097\/01.mcg.0000212608.59090.08"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36.  Suh              SK,                Hood              BL,                Kim              BJ,                Conrads              TP,                Veenstra              TD, and                Song              BJ.            Identification of oxidized mitochondrial proteins in alcohol-exposed            human hepatoma cells and mouse liver. Proteomics.            4: 3401\u20133412. 2004.","DOI":"10.1002\/pmic.200400971"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37.  Walsh              K, and                Alexander              G. Alcoholic            liver disease. Postgrad Med J. 76:            280\u2013286. 2000.","DOI":"10.1136\/pmj.76.895.280"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38.  Angulo              P. Nonalcoholic            fatty liver disease. N Engl J Med.          346: 1221\u20131231. 2002.","DOI":"10.1056\/NEJMra011775"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2018-0045\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T03:45:35Z","timestamp":1572061535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2018-0045\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2018-0045","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}